{"SPADE_UN_17653": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_17653", "Peptide Name": "PMAP-NC", "Source": "Synthetic (derived from PMAP-23)", "Family": "", "Gene": "Not found", "Sequence": "RIIDRLWLVRRPOKPKFVLVWVL", "Sequence Length": 23, "UniProt Entry": ["http://www.uniprot.org/uniprot/Notavailable"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Tumor cells:MDA361 (IC50=6.4µM); A549 (IC50=7.1µM)", "Hemolytic Activity": "Not available", "Cytotoxicity": "Not available", "Binding Target": "Not available", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Free", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C137H222N38O24", "Mass": 317810, "PI": 12.52, "Net Charge": 5, "Hydrophobicity": 0.413, "Half Life": "Mammalian:1 hourYeast:2 minE.coli:2 min", "Comments": "A unique structure with an amphipathic N-helix, a central hinge, and a hydrophobic C-helix is responsible for bactericidal and anticancer activity of PMAP-NC.", "Literature": [{"Title": "Rationally designed PMAP-23 derivatives with enhanced bactericidal and anticancer activity based on the molecular mechanism of peptide-membrane interactions", "Pubmed ID": "37310533", "Reference": "Amino Acids. 2023 Aug;55(8)1013-1022.", "Author": "Lee H, Shin SH, Yang S.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=37310533"}], "Frequent Amino Acids": "LRV", "Absent Amino Acids": "ACEGHMNQSTUY", "Basic Residues": 6, "Acidic Residues": 1, "Hydrophobic Residues": 15, "Polar Residues": 10, "Positive Residues": 6, "Negative Residues": 1, "Similar Sequences": [{"SPADE_ID": "SPADE_N_14408", "Similarity": 0.8636363636363636, "Sequence": "RIIDRLWRVRRPQKPKFVTVWVR"}, {"SPADE_ID": "SPADE_N_14410", "Similarity": 0.8636363636363636, "Sequence": "RIIDRLWRVRRPQKPKFVIVWVR"}, {"SPADE_ID": "SPADE_UN_22831", "Similarity": 0.8636363636363636, "Sequence": "RIIDRLWRVRRPQKPKFVTVWVR"}]}}}